alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
|Exhibit 32.1
|------------

CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Quadra Projects Inc. a Nevada corporation (the "Company") on Form 10-Q/A for the quarter ended May 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Claude Diedrick, President, Chief Executive Officer, Chief Financial Officer, Treasurer and Director of the Company, certifies to the best of his knowledge, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                              
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|   

/s/ Claude DiedrickClaude DiedrickPresident, Chief Executive Officer, ChiefFinancial Officer, Treasurer and DirectorDate: November 27, 2009

---
Exhibit
32.1





Certification
Pursuant to


18
U.S.C. Section 1350


As
Adopted Pursuant to


Section
906 of the Sarbanes-Oxley Act of 2002





In
connection with the Annual Report of GFR Pharmaceuticals, Inc. (the “Company”)
on Form 10-k for the year ended December 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Zhao Yan Ding,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, based on my
knowledge:





(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





Date:
April 15, 2010





GFR
PHARMACEUTICALS, INC.





/s/Zhao Yan
      DingZhao
      Yan Ding, Chief Executive Officer
Exhibit 10.19


 


Merisant Company 2 SARL


Avenue Jean-Jacques Rousseau 7


2000 Neuchatel


Switzerland


 


September 9, 2019


 


Albert Manzone


Dorfstrasse 3


Ch-8802 Kilchberg


 


Dear Albert:


 


I write to memorialize changes to your offer
letter dated January 25, 2016 (“Offer Letter”), which was amended on July 1, 2017 (“Amendment”), in a November
4, 2018 letter (“2018 Amendment Letter”), in a June 10, 2019 letter (“3rd Amendment”) and in
July 23, 2019 letter (“4th Amendment”). This amendment dated September 6, 2019 (“5th Amendment”)
will become effective on September 10, 2019, and except as otherwise provided herein, the terms of the Offer Letter, Amendment,
2018 Amendment Letter, and the 3rd Amendment will remain in full force and effect. Capitalized terms used but not defined
herein shall have the meaning set forth in the Offer Letter, the Amendment, or the 3rd Amendment as applicable (if,
in the event of a conflict, the meaning set forth in the Offer Letter shall govern).


 


The change in the above-referenced documents is as follows:


 


		1)	Effective September 10, 2019, section (1) of the 3rd Amendment, which replaced the first paragraph of Exhibit B
to the Amendment, is hereby struck in its entirety and replaced with the following:



 


Flavors Holdings Inc. (the “Company”)
would like to reward your continued future service as an employee, officer or director of the Company, the Employer, or any subsidiary
or affiliate thereof (collectively “Employee”), by granting you the right to earn a one-time bonus payable in
connection with a future Company Sale. Specifically, if you continue to remain an Employee through the closing date of the Company
Sale, the Employer or a subsidiary shall pay you a one-time cash bonus equal to $3,000,000 (the “Transaction Bonus”)
on or within five days following the closing date of such Company Sale. Notwithstanding the foregoing if a Company Sale is not
consummated on or prior to December 31, 2020, then this Exhibit B letter agreement (the “Agreement”) shall terminate
without any payment of the Transaction Bonus. For the avoidance of doubt, you shall only be entitled to the Transaction Bonus on
the first occurrence of a Company Sale and not on any subsequent Company Sale. If you are still employed and in good standing and
have not given notice of your resignation of employment, you shall be paid a one-time retention bonus of $500,000 on June 30, 2020
(the “Retention Bonus”) provided that the amount of the Retention Bonus paid, if any, shall reduce dollar for
dollar the amount of the Transaction Bonus. For the avoidance of doubt, this Retention Bonus and Transaction Bonus obligation does
not transfer to the buyer in the event of a Company Sale.


 






     


     


    

 


We look forward to continuing our mutually beneficial relationship.


 


	 	Very truly yours,
	 	 
	 	By:
	/s/ Paul G. Savas

	 	 
	 	Paul G. Savas




 


Please indicate your acceptance of this 3rd Amendment
by signing in the space below and returning a signed original amendment to me.


 


	Accepted:	/s/ Albert
Manzone
	 	Date:	September  9, 2019
	 	Albert Manzone
II 

116TH CONGRESS 

1ST SESSION S. 2494 

To direct the Secretary of Defense to provide travel to Dover Air Force 

Base for family members of members of the Armed Forces who die 

outside of the United States but not in a theater of combat operations 

so the family may receive the remains of the deceased, and for other 

purposes. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 18, 2019 

Mr. COTTON (for himself and Ms. DUCKWORTH) introduced the following bill; 

which was read twice and referred to the Committee on Armed Services 

A BILL 

To direct the Secretary of Defense to provide travel to Dover 

Air Force Base for family members of members of the 

Armed Forces who die outside of the United States but 

not in a theater of combat operations so the family 

may receive the remains of the deceased, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Fallen Heroes Family 

5 Travel Act of 2019’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•S 2494 IS

1 SEC. 2. TRANSPORTATION OF REMAINS OF CASUALTIES; 

2 TRAVEL EXPENSES FOR NEXT OF KIN. 

3 (a) TRANSPORTATION FOR REMAINS OF A MEMBER

4 WHO DIES NOT IN A THEATER OF COMBAT OPER5 ATIONS.—Section 562 of the John Warner National De6 fense Authorization Act for Fiscal Year 2007 (Public Law 

7 109–364; 10 U.S.C. 1482 note) is amended— 

8 (1) in the heading, by striking ‘‘DYING IN A

9 THEATER OF COMBAT OPERATIONS’’; and 

10 (2) in subsection (a), by striking ‘‘in a combat 

11 theater of operations’’ and inserting ‘‘outside of the 

12 United States’’. 

13 (b) TRANSPORTATION FOR FAMILY.—The Secretary 

14 of Defense shall revise Department of Defense Instruction 

15 1300.18 to extend travel privileges via Invitational Travel 

16 Authorization to family members of members of the 

17 Armed Forces who die outside of the United States and 

18 whose remains are returned to the United States through 

19 the mortuary facility at Dover Air Force Base, Delaware. 

Æ 


kjohnson on DSK79L0C42 with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PA-07-205 Research on the Economics of Diet, Activity, and Energy Balance.                    

*Date:*                         December 5, 2007.                    

*Time:*                         2:30 p.m. to 3:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).                    

*Contact Person:*                         John F. Connaughton, PhD, Scientific, Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7797,                         *connaughtonj@extra.niddk.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

      ( print page 64661)    
Dated: November 5, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-5680 Filed 11-15-07; 8:45 am]

BILLING CODE 4140-01-M
#### Sherry E. BRITTON, a minor by her father and next friend, Charles G. Britton, et al., Appellants, v. Robert S. FOLSOM, as President of the Board of Trustees of the Dallas Independent School District, Dallas County, Texas, et al., Appellees.

No. 22010.

United States Court of Appeals Fifth Circuit.

July 2, 1965.

W. J. Durham, Dallas, Tex., Norman Amaker, New York City, Fred J. Finch, Jr., Dallas, Tex., Jack Greenberg, New York City, for appellants.

Franklin E. Spafford, Donald G. Gay, Warren Whitham, Dallas, Tex., for respondents.

Before TUTTLE, Chief Judge, and HUTCHESON and BROWN, Circuit Judges.

BY THE COURT:

On the Appellants’ motion to advance consideration of the appeal from the order of September 4, 1964, denying an application for acceleration of the plan for desegregation of the Dallas Public Schools, the Court has taken the appeal under advisement on the briefs and rec*159ord. This includes the motion filed this day of the School District to dismiss the appeal on the ground that the School District on June 23, 1965, adopted a revised plan by which desegregation would be complete beginning September 1, 1967.

 As we assume that the revised plan was filed in, and will be complied with, good faith, the judgment appealed from is vacated and the cause remanded to the District Court for immediate hearings as required and the entry of appropriate orders. Singleton v. Jackson Municipal Separate School Dist., 5 Cir., 1965, 348 F.2d 729 [June 22, 1965]. In considering the revised plan and any amendments thereto, the District Court should require the desegregation of Grade 12 in 1965. Lockett v. Board of Educ. of Muscogee County School Dist., Ga., 5 Cir., 1965, 342 F.2d 225.

The mandate shall issue forthwith.
**EXHIBIT 21.1**

**SUBSIDIARIES OF KNOLOGY, INC.**

Knology Broadband, Inc. (Delaware) 

Knology of Central Florida, Inc. (Delaware) 

Knology Provider Solutions Group, Inc. (Delaware) 

Knology of Alabama, Inc. (Delaware) 

Knology ofAugusta, Inc. (Delaware) 

Knology of Charleston, Inc. (Delaware) 

Knology of Columbus, Inc. (Delaware) 

Knology of Florida, Inc. (Delaware) 

Knology of Georgia, Inc. (Delaware) 

Knology ofHuntsville, Inc. (Delaware) 

Knology of Knoxville, Inc. (Delaware) 

Knology of Montgomery, Inc. (Alabama) 

Knology of Nashville, Inc. (Delaware) 

Knology of South Carolina, Inc. (Delaware) 

Knology of South Dakota, Inc. (Delaware) 

Knology of Tennessee, Inc. (Delaware) 

GlobeTelecommunications, Inc. (Georgia) 

ITC Globe, Inc. (Delaware) 

Knology of the Valley, Inc. (Georgia) 

Valley Telephone Co., LLC (Alabama) 

PrairieWave Holdings, Inc. (Delaware) 

PrairieWave Communications, Inc. (Delaware) 

Knology of the Plains, Inc (Delaware) 

KnologyCommunity Telephone, Inc. (South Dakota) 

Knology of the Black Hills, LLC (South Dakota) 

Black Hills Fiber Systems, Inc. (South Dakota) 

Knology Condominium Association, Inc. (South Dakota) 

BHFC Publishing, LLC (Delaware) 

Knology Total Communications, Inc. (Alabama) 

Knology of the Wiregrass, Inc. (Alabama) 

Wiregrass Telcom, Inc. (Alabama) 

CommunicationsOne, Inc. (Alabama) 

Knology PCL, Inc. (Delaware) 

Knology of Kansas, Inc. (Delaware)
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Annual Report of Advance  Financial Bancorp (the
  "Company")  on Form  10-KSB for the year ended June 30, 2004 as filed with the
  Securities  and Exchange  Commission  on the date hereof (the  "Report"),  we,
  Stephen M. Gagliardi,  President and Chief Executive  Officer,  and Stephen M.
  Magnone, Chief Financial Officer,  certify, pursuant to 18 U.S.C. ss. 1350, as
  adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

           (1) The Report fully complies with the  requirements of section 13(a)
  or 15(d) of the Securities Exchange Act of 1934; and

           (2) The information  contained in the Report fairly presents,  in all
  material  respects,  the financial  condition and results of operations of the
  Company.




  /s/  Stephen M. Gagliardi                              /s/Stephen M. Magnone
  -------------------------------------                  -----------------------
  Stephen M. Gagliardi                                   Stephen M. Magnone
  President and Chief Executive Officer                  Chief Financial Officer



  September 21, 2004
EXHIBIT 31.2

                    Certification of Chief Financial Officer

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)


      In connection with the Annual Report of CanWest Petroleum Corporation (the
"Company") on Form 10-KSB for the annual period ended April 30, 2005 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
the undersigned certifies pursuant to 18 U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

      (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: July 28, 2005               By /s/ Thornton J. Donaldson
                                      ------------------------------------------
                                      Thornton J. Donaldson,
                                      President, Chief Financial Officer and
                                      Director
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of EXPLORE ANYWHERE HOLIDNG CORP. (the "Company") on Form 10-Q for the period ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Bryan Hammond, President (Principal Executive Officer) and Director of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date: November 19, 2012
/s/ Bryan HammondBryan HammondPresident, Principal Executive Officer
EXHIBIT 31.1






CERTIFICATION PURSUANT TO 18 U.S.C. ss. 1350,






AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002






I, Bryan Hammond, certify that:






1. I have reviewed this annual report on Form 10-Q/A of Explore Anywhere Holding Corp.






2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;






3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;






4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I have:




a)
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;









b)
evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within ninety (90) days prior to the filing date of this quarterly report (the "Evaluation Date"); and









c)
presented in this report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;




5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):




a)
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and









b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and




6. The registrant’s other certifying officer and I have indicated in this report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.






Date: July 1, 2011






/s/ Bryan Hammond






Name: Bryan Hammond






CEO and Member of the Board of Directors






(Principal Executive Officer)
IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF FLORIDA

PANAMA CITY DIVISION

DAVID W. KELSO,

Petitioner,

v. CASE NO. 5:10-cv-181-RS-CJK

KENNETH S. TUCKER,

Respondent.

_________________________________/

ORDER

Before me are the Magistrate Judge’s Report and Recommendation (Doc. 20),

Petitioner’s Objections (Doc. 21), and Petitioner’s Amendment to Objections (Doc. 22). I have 

considered Petitioner’s objections de novo.

IT IS ORDERED:

1. The Magistrate Judge’s Report and Recommendation is approved and 

incorporated in this Order.

2. Petitioner’s Petition for Writ of Habeas Corpus (Doc. 1) is DENIED. 

3. The certificate of appealability is DENIED because Defendant has not 

made a substantial showing of the denial of a constitutional right.

4. The clerk is directed to close the file.

ORDERED on July 31, 2012.

/S/ Richard Smoak 

RICHARD SMOAK

UNITED STATES DISTRICT JUDGE

Case 5:10-cv-00181-RS-CJK Document 23 Filed 07/31/12 Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                          44,265
<SECURITIES>                                         0
<RECEIVABLES>                                   41,208
<ALLOWANCES>                                         0
<INVENTORY>                                     51,105
<CURRENT-ASSETS>                               137,502
<PP&E>                                         127,219
<DEPRECIATION>                                  40,283
<TOTAL-ASSETS>                                 243,175
<CURRENT-LIABILITIES>                           49,598
<BONDS>                                        129,050
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        45,533
<OTHER-SE>                                    (13,535)
<TOTAL-LIABILITY-AND-EQUITY>                   243,175
<SALES>                                        104,352
<TOTAL-REVENUES>                               104,352
<CGS>                                           74,429
<TOTAL-COSTS>                                   74,429
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,177
<INCOME-PRETAX>                                 15,952
<INCOME-TAX>                                     4,786
<INCOME-CONTINUING>                             11,166
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,166
<EPS-PRIMARY>                                      .28
<EPS-DILUTED>                                      .28
        

</TABLE>